FDA approves new device for treating patients with CHF

  • The Optimizer Smart System, created by Impulse Dynamics, monitors heart activity and delivers non-excitatory electrical signals to the right heart valve.

  • The maker claims it provides patients with a higher quality of life and functional status, compared with those who only took medications.
  • Unlike a pacemaker, which regulates the rhythm of the heart, the OSS strengthens the muscle contractions.

The Food and Drug Administration approved a breakthrough medical device last week for patients suffering from chronic, hard-to-treat heart failure.

The Optimizer Smart System, created by Impulse Dynamics, monitors heart activity and delivers non-excitatory electrical signals to the right heart valve.

Source: CNBC